AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

QDMRD 400 Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Hydroxychloroquine (400mg)

Overview QDMRD 400 Tablet

Auranofin 400mg tablets are indicated for managing autoimmune disorders like rheumatoid arthritis and lupus. This medication mitigates disease advancement and alleviates pain, inflammation, and erythema. Additionally, it enhances glycemic management in patients with type 2 diabetes. Administer Auranofin 400mg with food to minimize gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic efficacy. Continue the prescribed regimen as directed, even with symptom improvement. Common adverse effects include nausea, emesis, diarrhea, and abdominal discomfort. Persistent or worsening side effects warrant immediate medical attention; your physician can offer strategies for symptom mitigation. Prior to commencing treatment, inform your doctor of any pre-existing cardiac, renal, or hepatic conditions, and list all concurrent medications. This medication is contraindicated with visual disturbances and prolonged pediatric use. Regular ophthalmological examinations may be recommended during treatment. Pregnant or lactating individuals should seek medical counsel before initiating therapy.

Uses of QDMRD 400 Tablet

Management of type 2 diabetes | Rheumatoid arthritis therapy | Systemic lupus erythematosus (SLE) management

Major Benefits of QDMRD 400 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the QDMRD 400 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of QDMRD 400 Tablet:

  • Skin rash
  • Itching
  • Affect lability
  • Abdominal pain
  • Blurred vision
  • Headache
  • Decreased appetite
  • Diarrhea
  • Vomiting
  • Nausea

How to use QDMRD 400 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the QDMRD 400 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How QDMRD 400 Tablet works:

QDMRD 400 Tablet, a disease-modifying antirheumatic medication (DMARD), reduces excessive immune system activity responsible for joint inflammation and pain. This action inhibits the underlying disease's advancement. Furthermore, it's hypothesized that the drug may enhance insulin responsiveness and pancreatic beta-cell activity, leading to improved blood sugar management in individuals with type 2 diabetes.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining alcohol and QDMRD 400 Tablets. Physician consultation is recommended.

PregnancyPregnancySAFE IF PRESCRIBED

Administration of 400 mg QDMRD tablets during gestation appears safe. Research predominantly indicates minimal or negligible fetal risk.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the 400mg QDMRD Tablet pose no known risk. Research in humans indicates minimal to negligible drug transfer via breast milk, posing no identified threat to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of QDMRD 400 Tablet, including potential vision problems.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using QDMRD 400 Tablets, potentially requiring a modified dosage. Physician consultation is advised. This medication may impact vision; therefore, routine eye examinations are recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should use QDMRD 400 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take QDMRD 400 Tablet :

Should you forget to take your QDMRD 400 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About QDMRD 400 Tablet

LabelValue
Type of Compound Aminoquinoline-based compound
Addictive None.
Medication Classification Pain relievers

FAQs on QDMRD 400 Tablet

Research is ongoing to evaluate the potential of QDMRD 400 Tablet to prevent and treat COVID-19. Preliminary laboratory testing indicates some antiviral activity against the novel coronavirus. Nevertheless, conclusive evidence of its efficacy against this virus requires additional clinical investigation.
India's COVID-19 national task force (established by the ICMR) advises using QDMRD 400 tablets solely for coronavirus prevention in select high-risk groups (individuals with elevated virus exposure risk) or emergencies. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 cases, and asymptomatic household members of confirmed cases.
We do not carry QDMRD 400 Tablets. If you believe you have a novel coronavirus infection, seek immediate medical attention and adhere to your doctor's instructions. Do not take QDMRD 400 Tablets without a prescription from a licensed physician.
The antiviral medication, QDMRD 400 Tablet, is indicated for coronavirus prophylaxis solely in specified high-risk populations or during public health emergencies. Adherence to the physician's prescribed dosage, schedule, and treatment length is mandatory.
The oral medication QDMRD 400 Tablet should be ingested with food or milk to minimize gastrointestinal discomfort. Adhere strictly to the prescribed dosage and duration, completing the entire course as directed by your physician. Consistent use, as per your doctor's instructions, is essential. Discontinue use only after consulting your doctor. If also using antacids, administer QDMRD 400 Tablet at least four hours before or after antacid consumption.
Individuals taking QDMRD 400 Tablets who experience symptoms consistent with COVID-19, including fever, dry cough, fatigue, or respiratory distress, must seek immediate medical attention. A physician will determine the need for coronavirus testing and isolation, and patients should adhere to all recommended medical guidance.
Hydroxychloroquine's therapeutic effects unfold gradually. Symptom improvement in rheumatoid arthritis and similar autoimmune conditions might not be apparent for several weeks, or even months. Consistent medication adherence is crucial during this period. Bridge therapy with supplemental drugs for interim symptom management may be provided by your physician.
While infrequent, hydroxychloroquine (HCQS) can impact vision, particularly with high doses or prolonged use (exceeding five years). Visual disturbances may manifest as difficulty reading or perceiving details (missing words, letters, or object parts), photosensitivity, blurred distance vision, and the perception of flashing or streaking lights. Report any such symptoms to your physician immediately. They may conduct ophthalmologic examinations and determine if HCQS discontinuation (via QDMRD 400 Tablet, for example) is necessary. Regular eye exams may also be recommended for patients on long-term HCQS therapy.
Prior to commencing HCQS therapy, an ophthalmological examination is mandatory, and subsequent evaluations should occur annually. Periodic monitoring of complete blood counts (CBC) and liver function tests (LFTs) may also be recommended by your physician. Treatment with HCQS may be ceased if any irregularities are identified.
The antimalarial drug, QDMRD 400 Tablet, possesses anti-inflammatory and immunomodulatory effects. It is non-steroidal, non-opioid, and lacks analgesic properties. In malaria, this medication eliminates the causative parasite. In rheumatoid arthritis, it mitigates joint inflammation, offering symptomatic relief.
Concurrent use of ibuprofen and HCQS is acceptable; these medications lack clinically significant interactions and do not demonstrably impair each other's efficacy.
Discontinuing HCQS without physician guidance may exacerbate your condition. Consequently, do not discontinue HCQS unless you have spoken with your doctor, even if symptoms improve.
Individuals with diabetes should exercise caution when taking HCQS. This medication can significantly reduce blood sugar, potentially causing severe hypoglycemia and loss of consciousness. Closely monitor blood glucose levels and seek immediate medical attention if a drop occurs. Your physician may adjust your diabetes medication dosage based on your blood sugar readings.
Hydroxychloroquine (HCQS) can be taken, but ensure at least four hours elapse between its administration and any antacid ingestion. Failure to observe this interval may compromise HCQS absorption and efficacy, potentially reducing its therapeutic effect.
Clinical trials are evaluating QDMRD 400 Tablet's potential to prevent and treat COVID-19. Preliminary laboratory findings suggest some antiviral activity against the novel coronavirus. Nevertheless, conclusive evidence of its efficacy against this virus is still pending.
The Indian Council of Medical Research (ICMR) convened a national COVID-19 task force, which advised employing QDMRD 400 Tablet solely for coronavirus infection prevention within specific, high-risk groups (namely, individuals with elevated virus exposure risk) or urgent circumstances. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 patients, and asymptomatic household members of positive cases.
We do not carry QDMRD 400 Tablets. If you believe you may have COVID-19, seek immediate medical attention and adhere to your physician's instructions. Do not take QDMRD 400 Tablets without a doctor's prescription. This medication requires a registered medical professional's authorization.
The antiviral medication, QDMRD 400 Tablet, is indicated for coronavirus prophylaxis solely in specified high-risk populations or urgent circumstances. Adherence to the physician's prescribed dosage, schedule, and treatment length is mandatory.
The oral medication QDMRD 400 Tablet is administered as a single tablet. To minimize gastrointestinal discomfort, it's recommended to ingest it with food or milk. Adhere strictly to the physician's prescribed dosage and treatment duration, completing the entire course. Consistent use, as directed by your doctor, is crucial. Discontinuation should only occur following consultation with your doctor. If concurrently using antacids, separate the intake of QDMRD 400 Tablet by at least four hours.
Individuals taking QDMRD 400 Tablets who experience symptoms consistent with a novel coronavirus infection—including elevated temperature, a dry cough, fatigue, and respiratory distress—must seek immediate medical attention. Their physician will determine the necessity of coronavirus testing and isolation, and all subsequent medical advice should be followed carefully.
The therapeutic effects of hydroxychloroquine may not be immediately apparent. Symptom improvement in rheumatoid arthritis and similar autoimmune conditions can take weeks, or even months. Consistent adherence to the prescribed dosage is crucial. Bridge therapy with supplemental medications may be utilized to manage symptoms while awaiting the full impact of hydroxychloroquine.
While infrequent, hydroxychloroquine (HCQS) can impact vision, particularly with high doses or prolonged use (exceeding five years). Visual disturbances may manifest as difficulty reading or perceiving details (missing words, letters, or object parts), photosensitivity, blurred distance vision, and the perception of flashing or streaking lights. Report any such symptoms to your physician promptly. They may conduct ophthalmological examinations and determine the need to cease HCQS treatment. Regular eye exams might also be recommended for individuals on long-term HCQS prescriptions.
Prior to commencing HCQS therapy, a comprehensive eye examination is mandatory, and subsequent examinations are recommended annually. Regular blood tests, including a complete blood count (CBC) and liver function tests (LFTs), may also be advised by your physician. Treatment with HCQS may be ceased if any irregularities are identified during these assessments.
The antimalarial drug QDMRD 400 Tablet possesses anti-inflammatory and immunomodulatory effects. It is not a steroid, opioid, or analgesic. In malaria, this medication eliminates the causative parasite. In rheumatoid arthritis, it mitigates joint inflammation, offering symptomatic relief.
Concurrent use of ibuprofen and HCQS is acceptable; these medications lack clinically significant interactions and do not adversely affect each other's efficacy.
Discontinuing HCQS treatment prematurely, without physician guidance, may lead to disease exacerbation. Consequently, do not discontinue HCQS unless your doctor advises you to do so, regardless of perceived improvement in your condition.
Individuals with diabetes should exercise caution when taking HCQS. This medication can significantly reduce blood glucose, potentially causing severe hypoglycemia and loss of consciousness. Close monitoring of blood glucose is essential; if levels drop, seek immediate medical attention. Your physician may adjust your anti-diabetic medication dosage based on your glucose readings.
Hydrochloroquine (HCQS) can be taken, but ensure a minimum four-hour interval separates its administration from any antacid medication. Failure to observe this interval may compromise HCQS absorption and efficacy, potentially reducing its therapeutic effect.
QDMRD 400 Tablet
109
MRP 126
13% off